Evidence map›Paper›PMID 27854229›Full record

ReviewJournal of neuromuscular diseases2016

Increasing Role of Titin Mutations in Neuromuscular Disorders.

Marco Savarese, Jaakko Sarparanta, Anna Vihola, Bjarne Udd, Peter Hackman

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neuromuscular diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 163 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Analysis ofCirculation. Genomic and precision medicine · 2025
    Article
  16. Article
  17. [Autosomal recessive limb-girdle muscular dystrophy-10. Case report].Revista medica del Instituto Mexicano del Seguro Social · 2025
    Article
  18. Neurology. Genetics · 2024
    Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marco SavareseFolkhälsan Institute of Genetics and Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, Finland.
Jaakko SarparantaFolkhälsan Institute of Genetics and Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, Finland.
Anna ViholaFolkhälsan Institute of Genetics and Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, Finland.
Bjarne UddFolkhälsan Institute of Genetics and Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, Finland.
Peter HackmanFolkhälsan Institute of Genetics and Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIAlbert Einstein College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The TTN gene with 363 coding exons encodes titin, a giant muscle protein spanning from the Z-disk to the M-band within the sarcomere. Mutations in the TTN gene have been associated with different genetic disorders, including hypertrophic and dilated cardiomyopathy and several skeletal muscle diseases.Before the introduction of next generation sequencing (NGS) methods, the molecular analysis of TTN has been laborious, expensive and not widely used, resulting in a limited number of mutations identified. Recent studies however, based on the use of NGS strategies, give evidence of an increasing number of rare and unique TTN variants. The interpretation of these rare variants of uncertain significance (VOUS) represents a challenge for clinicians and researchers.The main aim of this review is to describe the wide spectrum of muscle diseases caused by TTN mutations so far determined, summarizing the molecular findings as well as the clinical data, and to highlight the importance of joint efforts to respond to the challenges arising from the use of NGS. An international collaboration through a clinical and research consortium and the development of a single accessible database listing variants in the TTN gene, identified by high throughput approaches, may be the key to a better assessment of titinopathies and to systematic genotype- phenotype correlation studies.

Indexed as

ConnectinDistal MyopathiesGenetic Diseases, InbornHigh-Throughput Nucleotide SequencingHumansMuscular DiseasesMuscular Dystrophies, Limb-GirdleMuscular Dystrophy, Emery-DreifussMutationMyopathies, Structural, CongenitalNeuromuscular DiseasesOphthalmoplegiaRespiratory InsufficiencyRyanodine Receptor Calcium Release ChannelConnectinRyanodine Receptor Calcium Release ChannelTTN protein, humanChildhood-juvenile onset Emery-Dreifuss-like phenotype without cardiomyopathyCongenital centronuclear myopathy (CNM)Early-onset myopathy with fatal cardiomyopathy (EOMFC)Hereditary myopathy with early respiratory failure (HMERF)Late-onset autosomal dominant tibial muscular dystrophy (TMD)Limb-girdle muscular dystrophy (LGMD)Multi-minicore disease with heart disease (MmDHD)neuromuscular disorderstitinTTN

Identifiers

PMID27854229
PMCPMC5123623
OpenAlexW2507910676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.